Abstract
Autoimmune diseases are conditions in which the immune system damages the normal components of the individual. The etiology of autoimmune diseases is multifactorial and includes genetic, immune, hormonal and environmental factors (1), which are all combined to create the break in self-tolerance. Self-tolerance is normally maintained due to the balance between effector and suppressor T-cells (2). When this fragile equilibrium is distorted, either by activation of pathogenic effector T-cells, or by depletion of suppressor T-cells, the organism is prone to develop an autoimmune disease. The role of the thymus in these diseases is yet to be fully clarified, but this organ is widely accepted to be a major player in the maintenance of self-tolerance. Thus, on the one hand, the thymus helps prevent the development of autoimmunity, and on the other hand, it may participate in the initiation of autoimmune disease under certain conditions. Understanding the clinical and immunological response to thymectomy could shed light on the role of the thymus in autoimmune diseases. In this paper, we review the therapeutic as well as the pathogenic effects of thymectomy, which is intended to emphasize and clarify the pivotal role of the thymus in autoimmune diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Shoenfeld, Y. and Isenberg, D. (1989) Concluding remarks: the Mosaic of Auto-immunity, in The Mosaic of Autoimmunity (Shoenfeld, Y. and Isenberg, D., eds.), Elsevier, Amsterdam, pp. 509–511.
Tung, K. S. (1994) Mechanism of self-tolerance and events leading to autoimmune disease and autoantibody response. Clin. Immunol. Immunopathol. 73, 275–282.
Baraka, A. (1993) Anesthesia and myasthenia gravis. Middle East J. Anesthes. 12, 9–35.
Havard, C. W. H. and Fonseca, V. (1990) New treatment approaches to myasthenia gravis. Drugs 39, 66–73.
Keys, P. A. and Blume, R. P. (1991) Therapeutic strategies for myasthenia gravis. DICP 25, 1101–1108.
Tsuchiya, M., Asakura, H., and Yoshimatsu, H. (1989) Thymic abnormalities and autoimmune diseases. Keio. J. Med. 38, 383–402.
Wakkach, A., Guyon, T., Bruand, C., Tzartos, S., Cohen-Kaminsky, S., and Berrih-Aknin, S. (1996) Expression of acetylcholine receptor genes in human thymic epithelial cell. J. Immunol. 157, 3752–3760.
Matsui, M. and Kameyama, M. (1986) A double-label flow cytometric analysis of the simultaneous expression of OKT4 and Leu2a antigens on circulating T lymphocytes in myasthenia gravis. J. Neuroimmunol. 11, 311–319.
Cohen-Kaminsky, S., Devergne, O., Delattre, R. M., Klingel-Schmitt, I., Emilie, D., Galanaud, P., et al. (1993) Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia. Eur. Cytokine Netw. 4, 121–132.
Nyberg, H. R. and Gjerstad, L. (1988) Immunopharmacological treatment in myasthenia gravis. Transplant Proc. 20, 201–210.
De Bates, M. H. (1994) Autoimmune diseases against cell surface receptors: myasthenia gravis, a prototype anti-receptor disease. Nether. J. Med. 45, 294–301.
Mizuno, Y., Muraoka, M., Shimabukuro, K., Toda, K., Migagawa, K., Yoshimatsu, H., et al. (1990) Inflammatory bowel diseases and thymus disorder: reactivity of thymocytes with monoclonal antibodies. Bull. Tokyo Dent. Coll. 31, 137–141.
Bendixen, G. (1969) Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn’s disease. Gut 10, 631–636.
Tsuchiya, M., Asakura, H., and Yoshimatsu, H. (1989) Thymic abnormalities and autoimmune diseases. Keio J. Med. 38, 383–402.
Tsuchiya, M., Hibi, T., Watanabe, M., Ohara, M., Ogata, H., Iwao, Y., et al. (1991) Thymectomy in ulcerative colitis: a report of cases over a 13 year period. Thymus 17, 67–73.
D’Andrea, V., Meco, G., Corvese, F., Baselice, P. F., and Ambrogi, V. (1989) The role of the thymus in multiple sclerosis. Ital. J. Neurol. Sci. 10, 43–48.
Vein, A. M., Khomak, W.Y., Belokrinkij, D. V., Skrab, O. S., Golubkov, V. A., Ippolitov, I. Ch., et al. (1981) Thymectomy in multiple sclerosis. Sov. Med. 12, 42–45.
Trotter, J. L., Cliffort, B. D., Montgomery, E. B., and Ferguson, T. B. (1985) Thymectomy in multiple sclerosis: a three year follow-up. Neurology 35, 1049–1051.
D’Andrea, V., Malinovsky, L., Ambrogi, V., Artico, M., Capuanolg, L. G., Buccolini, F. et al. (1993) Thymectomy as treatment of autoimmune diseases other than myasthenia gravis. Thymus 21, 1–10.
Zandman, X., Goddard, G., Lorber, M., and Shoenfeld, Y. (1995) Systemic lupus erythematosus and thymoma-a double-edged sword. Int. Arch. Allergy Immunol. 108, 99–102.
Steven, M. M., Westedt, M. L., Euldering, F., Hazevoet, H. M., Dijkman, J. H., and Cats, A. (1984) SLE and invasive thymoma: report of two cases. Ann. Rheum. Dis. 43, 825–828.
Spuler, S., Sarropoulos, A., Mark, A., Hohlfeld, R., and Wekerle, H. (1996) Thymoma-associated myasthenia gravis. Transplantation of thymoma and extra-thymomal thymic tissue into SCID mice. Am. J. Pathol. 148, 1359–1365.
Geuder, K. I., Marx, A., Witzemann, V., Schalke, B., Kirchner, T., and Muller-Hermelink, H. K. (1992) Genomic organization and lack of the nicotinic acetylcholine receptor subunit genes in myasthenia gravis-associated thymoma. Lab. Invest. 66, 452–458.
Marx, A., Osborn, M., Tzartos, S., Geuder, K. I., Schalke, B., Nix, W., et al. (1992) A striational muscle antigen and myasthenia gravis-associated thymomas share anacetylcholine-receptorepitope. Dev. Immunol. 2, 77–84.
Marx, A., O’Connor, R., Geuder, K. I., Kirchner, T., and Muller-Hermelink, H. K. (1990) Characterization of a protein with an acetylcholine receptor-epitope from myasthenia gravis-associated thymomas. Lab. Invest. 62, 279–286.
Bonomo, A., Kehn, P. J., Payer, E., Rizzo, L., Cheever, A. W., and Shevach, E. M. (1995) Pathogenesis of post-thymectomy autoimmunity. Role of syngeneic MLR-reactive T cells. J. Immunol. 154, 6602–6611.
Brayman, K. L., Nakai, I., Field, M. J., Lloveras, J. J., Jessurun, J., Najarian, J. S., et al. (1992) Evaluation of intrathymic islet transplantation in the prediabetic period. Surgery 112, 319–326.
Khoury, S. J., Gallon, L., Chen, W., Betres, K., Russell, M. E., Hancock, W. W., et al. (1995) Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J. Exp. Med. 182, 357–366.
Khoury, S. J., Sayegh, M. H., Hancock, W. W., Gallon, L., Carpenter, C. B., and Weiner, H. L. (1993) Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalito-genic peptide. J. Exp. Med. 178, 559–566.
Zoneraich, S. (1994) Unraveling the conundrums of the diabetic heart diagnosed in 1876: prelude to genetics. Can. J. Cardiol. 10, 945–950.
Penhale, W. J., Stumbles, P. A., Huxtable, C. R., Sutherland, R. J., and Pethick, D. W. (1990) Induction of diabetes in PVG/c strain rats by manipulation of the immune system. Autoimmunity 7, 169–179.
Toh, B. H., van-Driel, I. R., and Gleeson, P. A. (1992) Autoimmune gastritis: tolerance and autoimmunity to the gastric H+/K+ ATPase (proton pump). Autoimmunity 13, 165–172.
Fukuma, K., Sakaguchi, S., Kuribayashi, K., Chen, W. L., Morishita, R., Sekita, K., et al. (1988) Immunologic and clinical studies on murine experimental autoimmune gastritis induced by neonatal thymectomy. Gastroenterology 94, 274–283.
Hayashi, Y. and Hirokawa, K. (1989) Immunopathology of experimental auto-allergic sialadenitis in C3H/He mice. Clin. Exp. Immunol. 75, 471–476.
Cohen, S. B. and Weetman, A. P. (1987) Characterization of different types of experimental autoimmune thyroiditis in the Buffalo strain rat. Clin. Exp. Immunol. 69, 25–32.
Stott, D. I., Hassman, R., Neilson, L., and McGregor, A. M. (1988) Analysis of the spectrotypes of autoantibodies against thyroglobulin in two rat models of autoimmune thyroiditis. Clin. Exp. Immunol. 73, 269–275.
Kobashi, H., Yamamoto, K., Yoshioka, T., Tomita, M., and Tsuji, T. (1994) Nonsuppurative cholangitis is induced in neonatally thymectomized mice: a possible animal model for primary biliary cirrhosis. Hepatology 19, 1424–1430.
Myozaki, M., Kamiyasu, M., Miura, T., Watanabe, Y., Nakanishi, T., and Yamashita, U. Induction of autoimmune hepatitis and autoantibodies to liver antigens by neonatal thymectomy in mice. Clin. Exp. Immunol. 104, 133–143.
Moncayo, R. and Moncayo, H. E. (1992) Autoimmunity and the ovary. Immunol. Today 13, 255–258.
Tung, K. S. and Lu, C. Y. (1991) Immunologie basis of reproductive failure. Monogr. Pathol. 33, 308–333.
Shoenfeld, Y. and Isenberg, D. (1989) Hormonal components and autoimmune diseases, in The Mosaic of Autoimmunity (Shoenfeld, Y. and Isenberg, D., eds.), Elsevier, Amsterdam, pp. 271–278.
Lo, D., Reilly, C., Marconi, L. A., Ogata, L., Wei, Q., Prud-homme, G., et al. (1995) Regulation of CD4 T cell reactivity to self and non-self. Int. Rev. Immunol. 13, 147–160.
Antonia, S. J., Geiger, T., Miller, J., and Flavell, R. A. (1995) Mechanisms of immune tolerance induction through the thymic expression of a peripheral tissue-specific protein. Int. Immunol. 7, 715–725.
Bonomo, A., Kehn, P. J., and Shevach, E. M. (1995) Post-thymectomy autoimmu-nity: abnormal T-cell homeostasis. Immunol. Today 16, 61–67.
Younus, J. and Ahmed, A. R. (1990) The relationship of pemphigus to neoplasia. J. Am. Acad. Dermatol. 23, 498–502.
Mevorach, D., Perrot, S., Buchanan, N. M., Khamashta, M., Laoussadi, S., Hughes, G. R. et al. (1995) Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature. Lupus 4, 33–37.
Petersen, P. and Lund, J. (1969) Systemic lupus erythematosus following thymectomy for myasthenia gravis. Dan. Med. Bull. 16, 179–181.
Goldman, M., Herode, A., Borenstein, S., and Zanen, A. (1984) Optic neuritis, transverse myelitis, and anti-DNA antibodies nine years after thymectomy for myasthenia gravis. Arthritis Rheum. 27, 701–703.
Grinlinton, F. M., Lynch, N. M., and Hart, H. H. (1991) A pair of monozygotic twins who are concordant for myasthenia gravis but became discordant for systemic lupus erythematosus post-thymectomy. Arthritis Rheum. 34, 916–919.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sherer, Y., Bar-Dayan, Y., Shoenfeld, Y. (1999). The Dual Relationship Between Thymectomy and Autoimmunity. In: Paul, S. (eds) Autoimmune Reactions. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-1610-0_23
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1610-0_23
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-7215-1
Online ISBN: 978-1-4612-1610-0
eBook Packages: Springer Book Archive